Bioactive Compounds Formulated in Phytosomes Administered as Complementary Therapy for Metabolic Disorders
International Journal of Molecular Sciences · 09.04.2024 · 25 (8) · 4162
DOI: 10.3390/ijms25084162 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.04.2024. Verfasst von Laura Toma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, 8 B.P. Haşdeu Street, 050568 Bucharest, Romania. Hauptthemen laut MEDLINE: Metabolic Diseases, Phytochemicals. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 243 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii, Ministerul Cercetării, Inovării și Digitalizării Romania, Romanian Academy and by the Romanian Ministry of Research, Innovation, and Digitization, CNCS/CCCDI-UEFISCDI.
Abstract (Originalsprache)
Metabolic disorders (MDs), including dyslipidemia, non-alcoholic fatty liver disease, diabetes mellitus, obesity and cardiovascular diseases are a significant threat to human health, despite the many therapies developed for their treatment. Different classes of bioactive compounds, such as polyphenols, flavonoids, alkaloids, and triterpenes have shown therapeutic potential in ameliorating various disorders. Most of these compounds present low bioavailability when administered orally, being rapidly metabolized in the digestive tract and liver which makes their metabolites less effective. Moreover, some of the bioactive compounds cannot fully exert their beneficial properties due to the low solubility and complex chemical structure which impede the passive diffusion through the intestinal cell membranes. To overcome these limitations, an innovative delivery system of phytosomes was developed. This review aims to highlight the scientific evidence proving the enhanced therapeutic benefits of the bioactive compounds formulated in phytosomes compared to the free compounds. The existing knowledge concerning the phytosomes’ preparation, their characterization and bioavailability as well as the commercially available phytosomes with therapeutic potential to alleviate MDs are concisely depicted. This review brings arguments to encourage the use of phytosome formulation to diminish risk factors inducing MDs, or to treat the already installed diseases as complementary therapy to allopathic medication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, 8 B.P. Haşdeu Street, 050568 Bucharest, Romania.
ORCID-Profile: Loredan Ştefan Niculescu
Förderung
- Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii
- Ministerul Cercetării, Inovării și Digitalizării Romania
- Romanian Academy and by the Romanian Ministry of Research, Innovation, and Digitization, CNCS/CCCDI-UEFISCDI
Zitieren
APA
Toma, L., Deleanu, M., Sanda, G. M., Barbălată, T., Niculescu, L. Ş., Sima, A. V., & Stancu, C. S. (2024). Bioactive Compounds Formulated in Phytosomes Administered as Complementary Therapy for Metabolic Disorders. International Journal of Molecular Sciences, 25(8), 4162. https://doi.org/10.3390/ijms25084162
Vancouver
Toma L, Deleanu M, Sanda GM, Barbălată T, Niculescu LŞ, Sima AV, et al. Bioactive Compounds Formulated in Phytosomes Administered as Complementary Therapy for Metabolic Disorders. International Journal of Molecular Sciences. 2024;25(8):4162. doi:10.3390/ijms25084162
BibTeX
@article{Toma2024,
author = {Toma, Laura and Deleanu, Mariana and Sanda, Gabriela Maria and Barbălată, Teodora and Niculescu, Loredan Ştefan and Sima, Anca Volumnia and Stancu, Camelia Sorina},
title = {Bioactive Compounds Formulated in Phytosomes Administered as Complementary Therapy for Metabolic Disorders},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {8},
pages = {4162},
doi = {10.3390/ijms25084162}
}
EUVIMED